Brain amyloid PET
2 papers2 findings
- Human trial1
- Humans1
Associations
1P-TAU181
upin humans1
1 study
P-TAU181
upin humans1
P-TAU181 predicts brain amyloid PET in humans.
“p-tau181 performed equivalent to or better than other biomarkers in predicting a brain Aβ-/+ status across the AD continuum.”
Humansacross the AD continuum
Alzheimer's & dementia : the journal of the Alzheimer's Association21 Jul 2022
P-TAU181 is associated with brain amyloid PET in humans.
“lower plasma Aβ1-42/Aβ1-40, and higher p-tau181 and GFAP were associated with increased Aβ-PET load prospectively.”
Humansacross the AD continuum7 to 10-year
Alzheimer's & dementia : the journal of the Alzheimer's Association21 Jul 2022
Latest
3 in 12 monthsAAIC 2025 Abstract
Whole Blood Gene Expression Network Expression Strongly Relates to Plasma pTau217 Levels
Cohort study of 724 peopleEpigenetic regulation of gene expression
AAIC 2025 Abstract
Lessons Learned in Study Recruitment from a Randomized Controlled Clinical Trial for Alzheimer's Disease Prevention
Cohort study of 1,735 peopleAlzheimer's disease
AAIC 2025 Abstract
Leveraging Routine Blood Tests, Plasma pTau‐217, and Machine Learning for Enhanced Detection and Monitoring of Preclinical Alzheimer's Disease
Cohort study of 420 peopleAlzheimer's disease
Alzheimer's & Dementia
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort
Cohort study in peopleAβ42